ERRγ impedes neuroendocrine prostate cancer development. [PDF]
Li T +8 more
europepmc +1 more source
Large-scale Genomic Landscape and Clinical Outcomes of De Novo and Treatment-emergent Neuroendocrine Prostate Cancer. [PDF]
Iida K +9 more
europepmc +1 more source
Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancer. [PDF]
Brown LG +23 more
europepmc +1 more source
Salvage Re-transurethral Resection of Prostate as a Diagnostic and Therapeutic Bridge in Treatment-Emergent Neuroendocrine Prostate Cancer: A Multimodal Management Paradigm. [PDF]
Kandhan L L +5 more
europepmc +1 more source
Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming. [PDF]
Ji Y +29 more
europepmc +1 more source
Neuroendocrine prostate cancer (NEPC) in focus: state of the art and future prospectives. [PDF]
Giunta EF +8 more
europepmc +1 more source
OPRK1 drives SLC9A3R1 progression to neuroendocrine prostate cancer. [PDF]
Liang L +6 more
europepmc +1 more source
Transcription Factor Dynamics in Neuroendocrine Prostate Cancer Development. [PDF]
Wang Y, Wang Y.
europepmc +1 more source
Genetic and epigenetic mechanisms underlying treatment-induced neuroendocrine prostate cancer. [PDF]
Keo V, Lu X, Zhao JC, Yu J.
europepmc +1 more source
Preclinical Activity of the DLL3-Targeted T-cell Engager MK-6070 in Neuroendocrine Prostate Cancer. [PDF]
Ku SY +7 more
europepmc +1 more source

